Avaden Biosciences is a renowned brand headquartered in Seattle, operating the largest human biosample network in the world. With over 35,000,000 highly annotated samples, Avaden offers immediate access to a wide range of patient data. The brand has established partnerships with more than 200 CLIA/CAP accredited facilities, providing researchers with the opportunity to acquire patient blood and freshly derived tissue from over 7,500 consented procedures per month.

Avaden's laboratory services include histology, pathology, and molecular services, with more than 1,500 clinically validated IHC, ISH, PCR, and NGS assays available. The brand also facilitates clinical trials and offers assay development and validation studies, ensuring high-quality results and reproducibility. What sets Avaden apart is their commitment to patient outcome longitudinal data.

The biospecimens collected by Avaden are linked to real-time, self-populating patient Electronic Medical Records (EMRs), offering detailed treatment, response, and outcome data. Avaden's team of board-certified pathologists reviews each sample to ensure accurate diagnosis and specifications, while adherence to ethical standards and the highest regulatory requirements is a top priority. With their expert solutions, global reach, and dedication to personalized healthcare advancements, Avaden Biosciences is at the forefront of accelerating biomarker discovery, molecular diagnostics, and personalized therapies